Enanta Pharmaceuticals
ENTA
#8252
Rank
ยฃ0.26 B
Marketcap
ยฃ8.96
Share price
-1.00%
Change (1 day)
-20.73%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : ยฃ0.14 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's total liabilities are ยฃ0.14 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Enanta Pharmaceuticals - Total liabilities on balance sheet (from 2011 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-09-30ยฃ0.16 B-13.28%
2024-09-30ยฃ0.18 B-7.96%
2023-09-30ยฃ0.20 B314.24%
2022-09-30ยฃ48.59 M66.3%
2021-09-30ยฃ29.22 M23.55%
2020-09-30ยฃ23.65 M6.33%
2019-09-30ยฃ22.24 M41.15%
2018-09-30ยฃ15.75 M-15.42%
2017-09-30ยฃ18.63 M112.95%
2016-09-30ยฃ8.74 M34.26%
2015-09-30ยฃ6.51 M56.28%
2014-09-30ยฃ4.16 M3.76%
2013-09-30ยฃ4.01 M-21.29%
2012-09-30ยฃ5.1 M92.52%
2011-09-30ยฃ2.65 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
ยฃ87.58 B 59,189.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ60.42 B 40,802.03%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
ยฃ106.37 B 71,913.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
ยฃ5.41 B 3,564.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ66.25 B 44,750.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ49.27 B 33,257.68%๐Ÿ‡บ๐Ÿ‡ธ USA